MNNGF (Baijin Life Science Holdings) PE Ratio without NRI: 75.00 (As of Jun. 30, 2026) — 14% Above Median


MNNGF Baijin Life Science Holdings Ltd MNNGF
34 GF Score
Price $0.08
GF Value $0.06
! 4 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings PE Ratio without NRI?

Baijin Life Science Holdings MNNGF 34 PE Ratio without NRI is 75.00 as of Jun. 30, 2026, which is 14% above its 10-year median of 66.00. GuruFocus rates MNNGF with a GF Score™ of 34/100 and a GF Value™ of $0.06. The stock has 4 warning signs investors should review. Among 806 Retail - Cyclical companies, Baijin Life Science Holdings ranks worse than 93.05% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-30), Baijin Life Science Holdings's share price is $0.075. Baijin Life Science Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 was $0.00. Therefore, Baijin Life Science Holdings's PE Ratio without NRI for today is 75.00.

During the past 12 years, Baijin Life Science Holdings's highest PE Ratio without NRI was 84.00. The lowest was 36.50. And the median was 66.00.

Baijin Life Science Holdings's EPS without NRI for the six months ended in Sep. 2025 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 was $0.00.

As of today (2026-06-30), Baijin Life Science Holdings's share price is $0.075. Baijin Life Science Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was $0.00. Therefore, Baijin Life Science Holdings's PE Ratio (TTM) for today is 75.00.

During the past years, Baijin Life Science Holdings's highest PE Ratio (TTM) was 84.00. The lowest was 36.50. And the median was 66.00.

Baijin Life Science Holdings's EPS (Diluted) for the six months ended in Sep. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was $0.00.

Baijin Life Science Holdings's EPS (Basic) for the six months ended in Sep. 2025 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 was $0.00.


Baijin Life Science Holdings  (OTCPK:MNNGF) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Baijin Life Science Holdings PE Ratio without NRI Related Terms


Baijin Life Science Holdings PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Baijin Life Science Holdings's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings PE Ratio without NRI Chart

Baijin Life Science Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss 71.00 At Loss At Loss

Baijin Life Science Holdings Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

MNNGF vs TPR: PE Ratio without NRI Comparison

For the Luxury Goods subindustry, Baijin Life Science Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baijin Life Science Holdings PE Ratio without NRI vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's PE Ratio without NRI falls into.


MNNGF
34GF Score
Baijin Life Science Holdings Ltd MNNGF
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baijin Life Science Holdings PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Baijin Life Science Holdings's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=0.075/0.001
=75

Baijin Life Science Holdings's Share Price of today is $0.075.
For company reported semi-annually, Baijin Life Science Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 75.00 mean?
Baijin Life Science Holdings (MNNGF) has a PE Ratio without NRI of 75.00 as of Jun. 30, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Baijin Life Science Holdings and its competitors. This is 14% above median its historical median of 66.00. Over the past decade, Baijin Life Science Holdings' PE Ratio without NRI has ranged from 36.50 to 84.00. According to the industry distribution chart, Baijin Life Science Holdings ranks #750 out of 806 companies in the Retail - Cyclical industry, placing it in the top 93.1%.
Is Baijin Life Science Holdings' PE Ratio without NRI too high?
Baijin Life Science Holdings' current PE Ratio without NRI of 75.00 is 14% above median its 10-year median of 66.00. Over the past 10 years, this metric has ranged from a low of 36.50 to a high of 84.00. The Retail - Cyclical industry median PE Ratio without NRI is 16.98. Baijin Life Science Holdings' value of 75.00 is 341.8% above this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #750 out of 806 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' PE Ratio without NRI compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #750 out of 806 companies for PE Ratio without NRI. This places Baijin Life Science Holdings in the lower half of its industry. The industry median PE Ratio without NRI is 16.98. Baijin Life Science Holdings' value of 75.00 is 341.8% above this benchmark. Historically, Baijin Life Science Holdings' own PE Ratio without NRI has ranged from 36.50 to 84.00 over the past decade. While the company's 10-year median is 66.00 vs. the industry median of 16.98, Baijin Life Science Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Retail - Cyclical company?
The median PE Ratio without NRI among Retail - Cyclical companies is 16.98, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current PE Ratio without NRI of 75.00 is 341.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median PE Ratio without NRI is 16.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current PE Ratio without NRI is 75.00, which is 14% above median its own 10-year median of 66.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current PE Ratio without NRI of 75.00. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 25% above its estimated fair value. The current PE Ratio without NRI is 75.00, which is 14% above median its 10-year median of 66.00 and 341.8% above the Retail - Cyclical industry median of 16.98. Baijin Life Science Holdings' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current PE Ratio without NRI is 75.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 25% above its estimated GF Value™ of $0.06.

Key valuation signals for MNNGF:

  • PE Ratio without NRI: 75.00 (14% above median its 10-year median of 66.00)
  • GF Value™: $0.06 vs. price of $0.08 (25% above fair value)
  • GF Score™: 34/100 with 4 warning signs
  • Industry Position: 341.8% above the Retail - Cyclical median (#750 of 806)

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
34GF Score

Get the complete analysis for MNNGF

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.06
GF Value